Navigation Links
New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting

on therapy unless the clinical benefits outweigh the risks. Blood counts should be monitored weekly for at least 8 weeks, or until recovery of adequate bone marrow function. Non-hematologic adverse events that occurred in 5% or more of patients and greater than placebo were pain flare (7%), diarrhea (6%), infection (7%), spinal cord compression (6.5%), arrhythmias (5%), and hematuria (5%). Patients who receive QUADRAMET should be advised that for several hours following administration, radioactivity will be present in excreted urine. To help protect themselves and others in their environment, precautions need to be taken for 12 hours following administration.

About Cytogen

Cytogen is a specialty pharmaceutical company dedicated to advancing the treatment and care of patients by building, developing, and commercializing a portfolio of oncology products. The Company's specialized sales force currently markets three therapeutic products and one diagnostic product to the U.S. oncology market. CAPHOSOL(R) is an advanced electrolyte solution for the treatment of oral mucositis and dry mouth that is approved in the U.S. as a prescription medical device. QUADRAMET(R) (samarium Sm-153 lexidronam injection) is approved for the treatment of pain in patients whose cancer has spread to the bone. PROSTASCINT(R) (capromab pendetide) is a PSMA-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer and SOLTAMOX(TM) (tamoxifen citrate) is the first liquid hormonal therapy approved in the U.S. for the treatment of breast cancer in adjuvant and metastatic settings. The Company is also developing CYT-500, a third-generation radiolabeled antibody to treat prostate cancer. Cytogen's product-focused strategy centers on attaining sustainable growth through clinical, commercial, and strategic initiatives.

A copy of the full prescribing information for CAPHOSOL, QUADRAMET, PROSTASCINT and SOLTAMOX, including Boxed Warnings, warnings, p
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Preclinical Data on Cytogens Technology to be Reported at the AACR Annual Meeting
2. New Clinical Data for Cytogens Quadramet and Prostacint to be Reported at Upcoming Major Medical Meetings
3. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
4. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
5. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
6. ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds for Solid Tumors Are to be Reported at ASCO
7. VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual Meeting
8. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
9. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
10. Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration
11. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Data for Cytogen QUADRAMET Reported Annual ASCO Meeting
(Date:9/3/2015)... 2015  Omeros Corporation (NASDAQ: OMER ) today ... Par Pharmaceutical, Inc. and its subsidiary, Par Sterile Products, ... the District of New Jersey ... of Delaware . The lawsuits were ... three Omeros patents, U.S. Patent Nos. 8,173,707, 8,586,633 and ...
(Date:9/3/2015)... Sep. 03, 2015 ... announced the addition of the "Investigation ... report to their offering. Non-steroidal ... chemical structure from steroids which have a ... provide analgestic and antipyretic effects with fewer ...
(Date:9/3/2015)... DUBLIN , Sep. 03, 2015 ... announced the addition of the "Investigation Report on ... Oxiracetam, a derivative of pyrrolidone, was first ... drug whose oral preparation and injection entered the Italian ... develops fast after entering China , ...
Breaking Medicine Technology:Omeros Files Infringement Suits Against Par 2Omeros Files Infringement Suits Against Par 3Omeros Files Infringement Suits Against Par 4China Flurbiprofen Market Investigation Report 2010-2019 2Investigation Report on China's Oxiracetam Market, 2010-2019 2
... April 21 Each year, the Food and Drug Administration (FDA) approves many ... , , ... , , This FDA ... October 2009 . , , , ...
... To enhance patient care management, Kaweah ... the wireless Draeger Infinity M300 patient-worn (telemetry) monitor. This ... both at the patient site and the central nursing ... achieve the best patient outcomes. Two-way communication with the ...
Cached Medicine Technology:FDA Consumer Health Information - Generic Drug Roundup: April 2010 2Draeger Infinity M300 Patient-Worn Monitors Help Improve Patient Care at Kaweah Delta Medical Center 2Draeger Infinity M300 Patient-Worn Monitors Help Improve Patient Care at Kaweah Delta Medical Center 3Draeger Infinity M300 Patient-Worn Monitors Help Improve Patient Care at Kaweah Delta Medical Center 4
(Date:9/3/2015)... ... September 03, 2015 , ... B. E. Smith, the only ... lead a national chief executive officer recruitment for Melissa Memorial Hospital ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:9/3/2015)... ... ... Global Vision , the world leader in the development of innovative ... inspection solutions, ScanProof and ArtProof at Packaging Innovations 2015. , Join ... , Be the first to get a sneak peek of Intelligent Proofreading. Global Vision’s ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters ... pleased to announce the additional of Carol Wysham, MD, to their esteemed Board ... Diana Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda ...
(Date:9/3/2015)... ... ... ProScrub is a set of automated tools that allow Final Cut Pro ... without the use of keyframes. Utilize ProScrub's powerful sliders to determine the number ... to energetic video productions. ProScrub is a Final Cut Pro X ...
(Date:9/3/2015)... ... 03, 2015 , ... AvePoint, the established leader in enabling enterprise ... 4 – AvePoint’s solution for facilitating two-way collaboration and external sharing without ever ... This is the fifth consecutive year an AvePoint product has made the list. ...
Breaking Medicine News(10 mins):Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4
... the disheartening reasons behind her recent weight loss. ... emaciated in all her recent public appearances, admitted that she ... revealed that her worrying weight loss is a result of ... lean and this year I lost my mom and I've ...
... Moylan of St.Lucie County was driven to a West ... for urgent treatment of a splitting headache. ... behind his right ear. And his wife April Moylan ... wife offered conflicting explanations throughout the day, the latter ...
... of the first studies of social sources of alcohol ... were willing to purchase alcohol for underage youth .Many ... Most of them obtain alcohol from social sources of ... opposed to commercial sources. , ,Many types ...
... to worry about the doctor's needle, for a new study ... just as well as injections. ,The first of ... showed that kids children given oral treatment recovered as quickly, ... were able to go home sooner than those given intravenous ...
... of CD38 gene prevented mice on high-fat diets from gaining weight. ... researchers led by Eduardo Chini at Mayo Clinic. ,As ... one with the gene CD38 and the other without. Each group ... fat. In a second test, each group was fed a standard ...
... Tuesday with the death of a ninth child who contracted ... centre said. ,The death came as a ... officials accused in the case for negligence, corruption and fraud. ... in prison. ,The accused have all denied the ...
Cached Medicine News:Health News:Headache Complaint Leads to Removal of Bullet 2Health News:Underage Youth Get Alcohol from Social Sources 2Health News:Underage Youth Get Alcohol from Social Sources 3Health News:Oral Treatment as Effective as Injections in Treating Kids With Pneumonia 2Health News:Boffins Identify Gene That Helps Regulates Body Weight 2
... The Stryker Threaded ... surgeon yet another choice ... tunnel. Dilators provide compaction ... The compaction of bone ...
... Stryker Conquest Suture Retrievers ... that pierce through soft ... through the tissue to ... Conquest Retrievers are front ...
... The Arthroscopy Scissor is ideal for excising ... tissue debris in the joint. The serrated edge ... as well as hold tissue within the jaws ... left and right jaw curvatures, are the perfect ...
... offers state-of-the-art quality in an instrument of ... durability. Low profile cutting tips allow access ... I instruments are available in just about ... required for large and small joint arthroscopic ...
Medicine Products: